{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:45:18Z","timestamp":1791319518545,"version":"4.3.1"},"reference-count":45,"publisher":"Impact Journals, LLC","issue":"25","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,6,20]]},"DOI":"10.18632\/oncotarget.17162","type":"journal-article","created":{"date-parts":[[2017,4,17]],"date-time":"2017-04-17T20:00:57Z","timestamp":1492459257000},"page":"41211-41226","source":"Crossref","is-referenced-by-count":43,"title":["New tumor suppressor microRNAs target glypican-3 in human liver cancer"],"prefix":"10.18632","volume":"8","author":[{"given":"Flora","family":"Cartier","sequence":"first","affiliation":[{"name":"University of Bordeaux, Inserm, Groupe de Recherche pour l\u2019Etude du Foie, GREF, U1053, F-33076 Bordeaux, France"},{"name":"University of Bordeaux, Inserm, Bioth\u00e9rapies des Maladies G\u00e9n\u00e9tiques Inflammatoires et Cancers, BMGIC, U1035, F-33076 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Indersie","sequence":"additional","affiliation":[{"name":"University of Bordeaux, Inserm, Groupe de Recherche pour l\u2019Etude du Foie, GREF, U1053, F-33076 Bordeaux, France"},{"name":"University of Bordeaux, Inserm, Bioth\u00e9rapies des Maladies G\u00e9n\u00e9tiques Inflammatoires et Cancers, BMGIC, U1035, F-33076 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lesjean","sequence":"additional","affiliation":[{"name":"University of Bordeaux, Inserm, Groupe de Recherche pour l\u2019Etude du Foie, GREF, U1053, F-33076 Bordeaux, France"},{"name":"University of Bordeaux, Inserm, Bioth\u00e9rapies des Maladies G\u00e9n\u00e9tiques Inflammatoires et Cancers, BMGIC, U1035, F-33076 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Charpentier","sequence":"additional","affiliation":[{"name":"University of Bordeaux, Inserm, Groupe de Recherche pour l\u2019Etude du Foie, GREF, U1053, F-33076 Bordeaux, France"},{"name":"University of Bordeaux, Inserm, Bioth\u00e9rapies des Maladies G\u00e9n\u00e9tiques Inflammatoires et Cancers, BMGIC, U1035, F-33076 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna B.","family":"Hooks","sequence":"additional","affiliation":[{"name":"University of Bordeaux, Inserm, Groupe de Recherche pour l\u2019Etude du Foie, GREF, U1053, F-33076 Bordeaux, France"},{"name":"University of Bordeaux, Inserm, Bioth\u00e9rapies des Maladies G\u00e9n\u00e9tiques Inflammatoires et Cancers, BMGIC, U1035, F-33076 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani","family":"Ghousein","sequence":"additional","affiliation":[{"name":"University of Bordeaux, Inserm, Groupe de Recherche pour l\u2019Etude du Foie, GREF, U1053, F-33076 Bordeaux, France"},{"name":"University of Bordeaux, Inserm, Bioth\u00e9rapies des Maladies G\u00e9n\u00e9tiques Inflammatoires et Cancers, BMGIC, U1035, F-33076 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9lique","family":"Desplat","sequence":"additional","affiliation":[{"name":"University of Bordeaux, Inserm, Groupe de Recherche pour l\u2019Etude du Foie, GREF, U1053, F-33076 Bordeaux, France"},{"name":"University of Bordeaux, Inserm, Bioth\u00e9rapies des Maladies G\u00e9n\u00e9tiques Inflammatoires et Cancers, BMGIC, U1035, F-33076 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Dugot-Senant","sequence":"additional","affiliation":[{"name":"INSERM US005 - TBM Core, Service for Experimental Histopathology, F-33000 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Tr\u00e9z\u00e9guet","sequence":"additional","affiliation":[{"name":"University of Bordeaux, F-33000 Bordeaux, France"},{"name":"CNRS, UMR5248, Chimie & Biologie des Membranes & des Nano-objets, CBMN, All\u00e9e Geoffroy Saint-Hilaire, B\u00e2t B14, F-33600 Pessac, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Sagliocco","sequence":"additional","affiliation":[{"name":"University of Bordeaux, Inserm, Groupe de Recherche pour l\u2019Etude du Foie, GREF, U1053, F-33076 Bordeaux, France"},{"name":"University of Bordeaux, Inserm, Bioth\u00e9rapies des Maladies G\u00e9n\u00e9tiques Inflammatoires et Cancers, BMGIC, U1035, F-33076 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hagedorn","sequence":"additional","affiliation":[{"name":"University of Bordeaux, Inserm, Groupe de Recherche pour l\u2019Etude du Foie, GREF, U1053, F-33076 Bordeaux, France"},{"name":"University of Bordeaux, Inserm, Bioth\u00e9rapies des Maladies G\u00e9n\u00e9tiques Inflammatoires et Cancers, BMGIC, U1035, F-33076 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe F.","family":"Grosset","sequence":"additional","affiliation":[{"name":"University of Bordeaux, Inserm, Groupe de Recherche pour l\u2019Etude du Foie, GREF, U1053, F-33076 Bordeaux, France"},{"name":"University of Bordeaux, Inserm, Bioth\u00e9rapies des Maladies G\u00e9n\u00e9tiques Inflammatoires et Cancers, BMGIC, U1035, F-33076 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,4,17]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nrclinonc.2015.121","article-title":"Advances in targeted therapies for hepatocellular carcinoma in the genomic era","volume":"12","author":"Finn","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.sempedsurg.2011.10.011","article-title":"Hepatoblastoma: recent developments in research and treatment","volume":"21","author":"von Schweinitz","year":"2012","journal-title":"Semin Pediatr Surg"},{"key":"3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.suronc.2016.03.002","article-title":"Hepatocellular carcinoma: From diagnosis to treatment","volume":"25","author":"Pawlik","year":"2016","journal-title":"Surg Oncol"},{"key":"4","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.humpath.2007.06.006","article-title":"Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases","volume":"39","author":"Yang","year":"2008","journal-title":"Hum Pathol"},{"key":"5","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1158\/0008-5472.CAN-04-4244","article-title":"Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling","volume":"65","author":"Filmus","year":"2005","journal-title":"Cancer Res"},{"key":"6","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1242\/jcs.140871","article-title":"Glypican-3 binds to Frizzled and plays a direct role in the stimulation of canonical Wnt signaling","volume":"127","author":"Filmus","year":"2014","journal-title":"J Cell Sci"},{"key":"7","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/hep.22202","article-title":"Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma","volume":"47","author":"Nagorney","year":"2008","journal-title":"Hepatology"},{"key":"8","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/hep.23848","article-title":"The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation","volume":"52","author":"Li","year":"2010","journal-title":"Hepatology"},{"key":"9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/gcc.22022","article-title":"The human sulfatase 2 inhibitor 2,4-disulfonylphenyl-tert-butylnitrone (OKN-007) has an antitumor effect in hepatocellular carcinoma mediated via suppression of TGFB1\/SMAD2 and Hedgehog\/GLI1 signaling","volume":"52","author":"Roberts","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"10","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1158\/0008-5472.CAN-09-1089","article-title":"Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma","volume":"69","author":"Friedman","year":"2009","journal-title":"Cancer Res"},{"key":"11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/hep.25994","article-title":"A functional screening identifies five micrornas controlling glypican-3: role of mir-1271 down-regulation in hepatocellular carcinoma","volume":"57","author":"Grosset","year":"2013","journal-title":"Hepatology"},{"key":"12","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/jcb.24404","article-title":"Knockdown of GPC3 inhibits the proliferation of Huh7 hepatocellular carcinoma cells through down-regulation of YAP","volume":"114","author":"Chen","year":"2013","journal-title":"J Cell Biochem"},{"key":"13","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/nar\/gkr843","article-title":"Molecular basis of differential target regulation by miR-96 and miR-182: the Glypican-3 as a model","volume":"40","author":"Grosset","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrg3965","article-title":"Towards a molecular understanding of microRNA-mediated gene silencing","volume":"16","author":"Izaurralde","year":"2015","journal-title":"Nat Rev Genet"},{"key":"15","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.cell.2013.03.043","article-title":"Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding","volume":"153","author":"Tollervey","year":"2013","journal-title":"Cell"},{"key":"16","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1261\/rna.036483.112","article-title":"MicroRNA-1291-mediated silencing of IRE1alpha enhances Glypican-3 expression","volume":"19","author":"Grosset","year":"2013","journal-title":"RNA"},{"key":"17","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","article-title":"MicroRNAs in cancer: biomarkers, functions and therapy","volume":"20","author":"Lawler","year":"2014","journal-title":"Trends Mol Med"},{"key":"18","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrd4359","article-title":"Therapeutic targeting of microRNAs: current status and future challenges","volume":"13","author":"Rana","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/hep4.1029","article-title":"MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting beta-catenin and Wnt signaling","volume":"1","author":"Fabre","year":"2017","journal-title":"Hepatol Comm"},{"key":"20","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1101\/gr.089367.108","article-title":"New class of microRNA targets containing simultaneous 5'-UTR and 3'-UTR interaction sites","volume":"19","author":"Athey","year":"2009","journal-title":"Genome Res"},{"key":"21","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/hepr.12121","article-title":"MicroRNA-520c-3p inhibits hepatocellular carcinoma cell proliferation and invasion through induction of cell apoptosis by targeting glypican-3","volume":"44","author":"Li","year":"2014","journal-title":"Hepatol Res"},{"key":"22","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.febslet.2012.02.017","article-title":"MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3","volume":"586","author":"Luo","year":"2012","journal-title":"FEBS Lett"},{"key":"23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/hep.21467","article-title":"Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets","volume":"45","author":"Zucman-Rossi","year":"2007","journal-title":"Hepatology"},{"key":"24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fgene.2012.00120","article-title":"miR-34 - a microRNA replacement therapy is headed to the clinic","volume":"3","author":"Bader","year":"2012","journal-title":"Frontiers in genetics"},{"key":"25","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1042\/BST0381608","article-title":"Analysis of post-transcriptional regulation using the FunREG method","volume":"38","author":"Grosset","year":"2010","journal-title":"Biochem Soc Trans"},{"key":"26","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1074\/mcp.M800503-MCP200","article-title":"Analysis of post-transcriptional regulations by a functional, integrated, and quantitative method","volume":"8","author":"Grosset","year":"2009","journal-title":"Mol Cell Proteomics"},{"key":"27","doi-asserted-by":"crossref","first-page":"8358","DOI":"10.1073\/pnas.150152697","article-title":"Association of Smads with lymphoid enhancer binding factor 1\/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways","volume":"97","author":"Attisano","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"28","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1053\/j.gastro.2015.02.056","article-title":"beta-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis","volume":"148","author":"Monga","year":"2015","journal-title":"Gastroenterology"},{"key":"29","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1073\/pnas.0408622102","article-title":"Accessing key steps of human tumor progression in vivo by using an avian embryo model","volume":"102","author":"Bikfalvi","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"30","article-title":"Netrin-1 mediates early events in pancreatic adenocarcinoma progression, acting on tumor and endothelial cells","volume":"138","author":"Hagedorn","year":"2010","journal-title":"Gastroenterology"},{"key":"31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.molcel.2012.10.008","article-title":"Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer","volume":"49","author":"Kim","year":"2013","journal-title":"Mol Cell"},{"key":"32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/cbf.2863","article-title":"miR-203 inhibits proliferation of HCC cells by targeting survivin","volume":"31","author":"Jisheng","year":"2013","journal-title":"Cell Biochem Funct"},{"key":"33","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/cdd.2014.136","article-title":"MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches","volume":"22","author":"Negrini","year":"2015","journal-title":"Cell Death Differ"},{"key":"34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/onc.2013.54","article-title":"Roles of microRNAs during prostatic tumorigenesis and tumor progression","volume":"33","author":"Gao","year":"2014","journal-title":"Oncogene"},{"key":"35","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1038\/onc.2015.89","article-title":"MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment","volume":"34","author":"Peter","year":"2015","journal-title":"Oncogene"},{"key":"36","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.bbagen.2014.01.022","article-title":"MicroRNA-dependent targeting of the extracellular matrix as a mechanism of regulating cell behavior","volume":"1840","author":"Gotte","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"37","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/hep.25891","article-title":"Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma","volume":"56","author":"Chen","year":"2012","journal-title":"Hepatology"},{"key":"38","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/hep.21328","article-title":"Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas","volume":"44","author":"Michalopoulos","year":"2006","journal-title":"Hepatology"},{"key":"39","doi-asserted-by":"crossref","first-page":"e0120024","DOI":"10.1371\/journal.pone.0120024","article-title":"Identification and validation of potential biomarkers for the detection of dysregulated microRNA by qPCR in patients with colorectal adenocarcinoma","volume":"10","author":"Xu","year":"2015","journal-title":"PLoS One"},{"key":"40","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.canlet.2006.12.024","article-title":"Connexin 43 expression promotes malignancy of HuH7 hepatocellular carcinoma cells via the inhibition of cell-cell communication","volume":"252","author":"Morita","year":"2007","journal-title":"Cancer Lett"},{"key":"41","first-page":"3018","article-title":"Overexpression of sineoculis homeobox homolog 1 predicts poor prognosis of hepatocellular carcinoma","volume":"7","author":"Lin","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"42","doi-asserted-by":"publisher","first-page":"10307","DOI":"10.18632\/oncotarget.2537","article-title":"Overexpression of platelet-derived growth factor receptor alpha promotes tumor progression and indicates poor prognosis in hepatocellular carcinoma","volume":"5","author":"Zhang","year":"2014","journal-title":"Oncotarget"},{"key":"43","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1038\/mtna.2015.23","article-title":"siRNA Versus miRNA as Therapeutics for Gene Silencing","volume":"4","author":"Leung","year":"2015","journal-title":"Mol Ther Nucleic Acids"},{"key":"44","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1083\/jcb.141.6.1407","article-title":"OCI-5\/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner","volume":"141","author":"Filmus","year":"1998","journal-title":"J Cell Biol"},{"key":"45","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1126\/science.275.5307.1784","article-title":"Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-\/- colon carcinoma","volume":"275","author":"Clevers","year":"1997","journal-title":"Science"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T20:03:12Z","timestamp":1589140992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,17]]},"references-count":45,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2017,6,20]]}},"alternative-id":["17162","28476031"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.17162","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,17]]}}}